Blue Earth celebrates new addition to EAU guidelines

16 May 2019


Blue Earth Logo

Axumin® (fluciclovine (18F)) has been added to EAU Guidelines for imaging in patients with biochemical recurrence in prostate cancer, which is a clear recognition of the value of Axumin® in Europe. The guidelines help clinicians make informed decisions in a given circumstance; taking the highest quality scientific data, their patient’s personal circumstances, values and preferences into account. 

British Institute of Radiology - Cookie Disclaimer

The British Institute of Radiology website uses cookies to provide you with essential online features. If you continue to use our site without changing your browser settings, we'll assume you are happy to receive cookies. Please read our Cookie policy for more information.